<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>米内网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-17T20:17:45+08:00</updated>
  <subtitle>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>东阳光药大丰收！拿下14个重磅品种，“猛攻”600亿糖尿病市场，首个1类新药将获批</title>
    <updated>2020-12-17T16:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/oA1W_WkGlyqOlY6Exb0e-Q</id>
    <link href="https://mp.weixin.qq.com/s/oA1W_WkGlyqOlY6Exb0e-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】汇宇紫杉醇注射液将获批，超75亿市场生变</title>
    <updated>2020-12-17T16:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/q7dFvErnBeVojHNiTTKfeQ</id>
    <link href="https://mp.weixin.qq.com/s/q7dFvErnBeVojHNiTTKfeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】齐鲁又一品种首家过评，原研药再现危机？</title>
    <updated>2020-12-17T16:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/g4lfwKsjOqhxpWYJJSBkVQ</id>
    <link href="https://mp.weixin.qq.com/s/g4lfwKsjOqhxpWYJJSBkVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【焦点】科伦将拿下6亿注射剂，7款注射剂已过评</title>
    <updated>2020-12-17T16:23:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/n7Z8Wk7HFoMy86VZ8powzQ</id>
    <link href="https://mp.weixin.qq.com/s/n7Z8Wk7HFoMy86VZ8powzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“一哥”易主，29个独家中成药亮了！2大品种首超10亿，扬子江、片仔癀......逆势大涨</title>
    <updated>2020-12-16T16:00:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/ylAkPl1AIBsJKYtCKLBFKA</id>
    <link href="https://mp.weixin.qq.com/s/ylAkPl1AIBsJKYtCKLBFKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】科伦又有1类新药来袭！15个重磅新品已获批</title>
    <updated>2020-12-16T16:00:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/L6sSzFJfOy09MEXzh68_Hw</id>
    <link href="https://mp.weixin.qq.com/s/L6sSzFJfOy09MEXzh68_Hw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【聚焦】这家四川药企厉害，暴涨200%抗血栓注射剂首家过评</title>
    <updated>2020-12-16T16:00:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/1Nlnwrq5as8EV3ChVugjkQ</id>
    <link href="https://mp.weixin.qq.com/s/1Nlnwrq5as8EV3ChVugjkQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【关注】泰德将拿下最畅销的肌松药，冲击恒瑞7成市场</title>
    <updated>2020-12-16T16:00:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/auDdIpCP04R3nOGJ6RU7ZQ</id>
    <link href="https://mp.weixin.qq.com/s/auDdIpCP04R3nOGJ6RU7ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采揭幕，中成药未纳入！肝炎药王稳坐霸主，1类新药开辟化药领地</title>
    <updated>2020-12-15T15:58:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/8NhNVqQJZ6UPRv9ex1DLdw</id>
    <link href="https://mp.weixin.qq.com/s/8NhNVqQJZ6UPRv9ex1DLdw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】恒瑞、海思科……14个1类新药获批，东阳光药来了</title>
    <updated>2020-12-15T15:58:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/FxJkSWWSZ2_yUmf1FyT9uQ</id>
    <link href="https://mp.weixin.qq.com/s/FxJkSWWSZ2_yUmf1FyT9uQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】3000万喜提胰岛素冠军产品！甘李拿下国内首家</title>
    <updated>2020-12-15T15:58:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/wpsvXv5MKH-Qv2Zl2sMb8Q</id>
    <link href="https://mp.weixin.qq.com/s/wpsvXv5MKH-Qv2Zl2sMb8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【焦点】恩华抢先人福夺首家过评！20亿麻醉剂原研败北</title>
    <updated>2020-12-15T15:58:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/bQTSXV4h6QKy-RwXETr89g</id>
    <link href="https://mp.weixin.qq.com/s/bQTSXV4h6QKy-RwXETr89g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10亿中成药贴膏剂或创新高！奇正、羚锐、康缘……抢占TOP10，6个过亿独家产品亮眼</title>
    <updated>2020-12-14T16:15:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/d-WsfjpqTgQTk6HgNM7KVA</id>
    <link href="https://mp.weixin.qq.com/s/d-WsfjpqTgQTk6HgNM7KVA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【上市】重组蛋白行业龙头来了！科兴制药登陆科创板</title>
    <updated>2020-12-14T16:15:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/8jy24qcIqPLD9p5uQ3BlQg</id>
    <link href="https://mp.weixin.qq.com/s/8jy24qcIqPLD9p5uQ3BlQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【关注】恒瑞又有新动作！南方总部及研发中心项目建设正式启动</title>
    <updated>2020-12-14T16:15:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/CdjzAqnVwXHPcU207DSHrg</id>
    <link href="https://mp.weixin.qq.com/s/CdjzAqnVwXHPcU207DSHrg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【获批】健康元搅局80亿吸入剂！阿斯利康9成市场再受冲击</title>
    <updated>2020-12-14T16:15:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/KZwRGdIYUMVK5qLCWsqqnw</id>
    <link href="https://mp.weixin.qq.com/s/KZwRGdIYUMVK5qLCWsqqnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百强工业、零售连锁“集结”！双鲸、奇正……创新升级推动工商共赢</title>
    <updated>2020-12-13T07:58:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/JVD7CQdGmq_uT-YB39shXg</id>
    <link href="https://mp.weixin.qq.com/s/JVD7CQdGmq_uT-YB39shXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【热议】创新当道，百强企业如何转型升级？天士力、众生、太极......大咖支招</title>
    <updated>2020-12-13T07:58:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/RvpXn6O5_IR1RtmR0RvukQ</id>
    <link href="https://mp.weixin.qq.com/s/RvpXn6O5_IR1RtmR0RvukQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【关注】65%上市药企布局医疗器械，“药械融合”迈进新风口！</title>
    <updated>2020-12-13T07:58:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-13:/s/K5BU2VUNlATVZm31J2I4-w</id>
    <link href="https://mp.weixin.qq.com/s/K5BU2VUNlATVZm31J2I4-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴、恒瑞、信达……国产新药加速20000亿市场洗牌！申报新趋势是这些？</title>
    <updated>2020-12-11T20:29:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/hwLMZOKdkKwdbcEXcHj8Sw</id>
    <link href="https://mp.weixin.qq.com/s/hwLMZOKdkKwdbcEXcHj8Sw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>